Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques

Yiannis S. Chatzizisis, Michael Jonas, Roy Beigel, Ahmet U. Coskun, Aaron B. Baker, Benjamin V. Stone, Charles Maynard, Ross G. Gerrity, William Daley, Elazer R. Edelman, Charles L. Feldman, Peter H. Stone

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Aims: We investigated the role of Valsartan (V) alone or in combination with Simvastatin (S) on coronary atherosclerosis and vascular remodeling, and tested the hypothesis that V or V/S attenuate the pro-inflammatory effect of low endothelial shear stress (ESS). Methods: Twenty-four diabetic, hyperlipidemic swine were allocated into Early (n = 12) and Late (n = 12) groups. In each group animals were treated with Placebo (n = 4), V (n = 4) and V/S (n = 4) and followed for 8 weeks in the Early group and 30 weeks in the Late group. Blood pressure, serum cholesterol and glucose were similar across the treatment subgroups. ESS was calculated in plaque-free subsegments of interest (n = 109) in the Late group at week 23. Coronary arteries of this group were harvested at week 30, and the subsegments of interest were identified, and analyzed histopathologically. Results: V alone or with S reduced the severity of inflammation in high-risk plaques. Both regimens attenuated the severity of enzymatic degradation of the arterial wall, reducing the severity of expansive remodeling. V alone or with S attenuated the pro-inflammatory effect of low ESS. Conclusions: V alone or with S exerts a beneficial effect of reducing and stabilizing high-risk plaque characteristics independent of a blood pressure- and lipid-lowering effect.

Original languageEnglish (US)
Pages (from-to)387-394
Number of pages8
JournalAtherosclerosis
Volume203
Issue number2
DOIs
StatePublished - Apr 1 2009

Fingerprint

Valsartan
Simvastatin
Atherosclerotic Plaques
Blood Pressure
Inflammation
Coronary Artery Disease
Coronary Vessels
Swine
Cholesterol
Placebos
Lipids
Glucose
Serum
Therapeutics

Keywords

  • Angiotensin receptor blocker
  • Atherosclerosis
  • Inflammation
  • Shear stress
  • Vascular remodeling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques. / Chatzizisis, Yiannis S.; Jonas, Michael; Beigel, Roy; Coskun, Ahmet U.; Baker, Aaron B.; Stone, Benjamin V.; Maynard, Charles; Gerrity, Ross G.; Daley, William; Edelman, Elazer R.; Feldman, Charles L.; Stone, Peter H.

In: Atherosclerosis, Vol. 203, No. 2, 01.04.2009, p. 387-394.

Research output: Contribution to journalArticle

Chatzizisis, YS, Jonas, M, Beigel, R, Coskun, AU, Baker, AB, Stone, BV, Maynard, C, Gerrity, RG, Daley, W, Edelman, ER, Feldman, CL & Stone, PH 2009, 'Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques', Atherosclerosis, vol. 203, no. 2, pp. 387-394. https://doi.org/10.1016/j.atherosclerosis.2008.07.032
Chatzizisis, Yiannis S. ; Jonas, Michael ; Beigel, Roy ; Coskun, Ahmet U. ; Baker, Aaron B. ; Stone, Benjamin V. ; Maynard, Charles ; Gerrity, Ross G. ; Daley, William ; Edelman, Elazer R. ; Feldman, Charles L. ; Stone, Peter H. / Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques. In: Atherosclerosis. 2009 ; Vol. 203, No. 2. pp. 387-394.
@article{834f109b81964a119b6caadabd32dda6,
title = "Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques",
abstract = "Aims: We investigated the role of Valsartan (V) alone or in combination with Simvastatin (S) on coronary atherosclerosis and vascular remodeling, and tested the hypothesis that V or V/S attenuate the pro-inflammatory effect of low endothelial shear stress (ESS). Methods: Twenty-four diabetic, hyperlipidemic swine were allocated into Early (n = 12) and Late (n = 12) groups. In each group animals were treated with Placebo (n = 4), V (n = 4) and V/S (n = 4) and followed for 8 weeks in the Early group and 30 weeks in the Late group. Blood pressure, serum cholesterol and glucose were similar across the treatment subgroups. ESS was calculated in plaque-free subsegments of interest (n = 109) in the Late group at week 23. Coronary arteries of this group were harvested at week 30, and the subsegments of interest were identified, and analyzed histopathologically. Results: V alone or with S reduced the severity of inflammation in high-risk plaques. Both regimens attenuated the severity of enzymatic degradation of the arterial wall, reducing the severity of expansive remodeling. V alone or with S attenuated the pro-inflammatory effect of low ESS. Conclusions: V alone or with S exerts a beneficial effect of reducing and stabilizing high-risk plaque characteristics independent of a blood pressure- and lipid-lowering effect.",
keywords = "Angiotensin receptor blocker, Atherosclerosis, Inflammation, Shear stress, Vascular remodeling",
author = "Chatzizisis, {Yiannis S.} and Michael Jonas and Roy Beigel and Coskun, {Ahmet U.} and Baker, {Aaron B.} and Stone, {Benjamin V.} and Charles Maynard and Gerrity, {Ross G.} and William Daley and Edelman, {Elazer R.} and Feldman, {Charles L.} and Stone, {Peter H.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1016/j.atherosclerosis.2008.07.032",
language = "English (US)",
volume = "203",
pages = "387--394",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques

AU - Chatzizisis, Yiannis S.

AU - Jonas, Michael

AU - Beigel, Roy

AU - Coskun, Ahmet U.

AU - Baker, Aaron B.

AU - Stone, Benjamin V.

AU - Maynard, Charles

AU - Gerrity, Ross G.

AU - Daley, William

AU - Edelman, Elazer R.

AU - Feldman, Charles L.

AU - Stone, Peter H.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Aims: We investigated the role of Valsartan (V) alone or in combination with Simvastatin (S) on coronary atherosclerosis and vascular remodeling, and tested the hypothesis that V or V/S attenuate the pro-inflammatory effect of low endothelial shear stress (ESS). Methods: Twenty-four diabetic, hyperlipidemic swine were allocated into Early (n = 12) and Late (n = 12) groups. In each group animals were treated with Placebo (n = 4), V (n = 4) and V/S (n = 4) and followed for 8 weeks in the Early group and 30 weeks in the Late group. Blood pressure, serum cholesterol and glucose were similar across the treatment subgroups. ESS was calculated in plaque-free subsegments of interest (n = 109) in the Late group at week 23. Coronary arteries of this group were harvested at week 30, and the subsegments of interest were identified, and analyzed histopathologically. Results: V alone or with S reduced the severity of inflammation in high-risk plaques. Both regimens attenuated the severity of enzymatic degradation of the arterial wall, reducing the severity of expansive remodeling. V alone or with S attenuated the pro-inflammatory effect of low ESS. Conclusions: V alone or with S exerts a beneficial effect of reducing and stabilizing high-risk plaque characteristics independent of a blood pressure- and lipid-lowering effect.

AB - Aims: We investigated the role of Valsartan (V) alone or in combination with Simvastatin (S) on coronary atherosclerosis and vascular remodeling, and tested the hypothesis that V or V/S attenuate the pro-inflammatory effect of low endothelial shear stress (ESS). Methods: Twenty-four diabetic, hyperlipidemic swine were allocated into Early (n = 12) and Late (n = 12) groups. In each group animals were treated with Placebo (n = 4), V (n = 4) and V/S (n = 4) and followed for 8 weeks in the Early group and 30 weeks in the Late group. Blood pressure, serum cholesterol and glucose were similar across the treatment subgroups. ESS was calculated in plaque-free subsegments of interest (n = 109) in the Late group at week 23. Coronary arteries of this group were harvested at week 30, and the subsegments of interest were identified, and analyzed histopathologically. Results: V alone or with S reduced the severity of inflammation in high-risk plaques. Both regimens attenuated the severity of enzymatic degradation of the arterial wall, reducing the severity of expansive remodeling. V alone or with S attenuated the pro-inflammatory effect of low ESS. Conclusions: V alone or with S exerts a beneficial effect of reducing and stabilizing high-risk plaque characteristics independent of a blood pressure- and lipid-lowering effect.

KW - Angiotensin receptor blocker

KW - Atherosclerosis

KW - Inflammation

KW - Shear stress

KW - Vascular remodeling

UR - http://www.scopus.com/inward/record.url?scp=62649146826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62649146826&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2008.07.032

DO - 10.1016/j.atherosclerosis.2008.07.032

M3 - Article

C2 - 18786669

AN - SCOPUS:62649146826

VL - 203

SP - 387

EP - 394

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -